Cargando…

Optimising an Infusion Protocol Containing Cefepime to Limit Particulate Load to Newborns in a Neonatal Intensive Care Unit

Background: In neonatal intensive care units (NICUs), the simultaneous administration of drugs requires complex infusion methods. Such practices can increase the risk of drug incompatibilities resulting in the formation of a particulate load with possible clinical consequences. Methods: This paper e...

Descripción completa

Detalles Bibliográficos
Autores principales:	Martin Mena, Anthony, Masse, Morgane, Négrier, Laura, Nguyen, Thu Huong, Ladam, Bruno, Storme, Laurent, Barthélémy, Christine, Odou, Pascal, Genay, Stéphanie, Décaudin, Bertrand
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2021
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8001063/ https://www.ncbi.nlm.nih.gov/pubmed/33800228 http://dx.doi.org/10.3390/pharmaceutics13030351

Ejemplares similares

Effectiveness of in-Line Filters to Completely Remove Particulate Contamination During a Pediatric Multidrug Infusion Protocol
por: Perez, Maxime, et al.
Publicado: (2018)

In vitro assessment of the influence of intravenous extension set materials on insulin aspart drug delivery
por: Masse, Morgane, et al.
Publicado: (2018)

Case report: risk of skin necrosis related to injectable vancomycin in critically ill newborn infants
por: Gilliot, Sixtine, et al.
Publicado: (2021)

Analysis of particulate exposure during continuous drug infusion in critically ill adult patients: a preliminary proof-of-concept in vitro study
por: Benlabed, Malik, et al.
Publicado: (2018)

Disturbance of Vancomycin Infusion Flow during Multidrug Infusion: Influence on Endothelial Cell Toxicity
por: Drouet, Maryline, et al.
Publicado: (2021)

Dynamic Image Analysis To Evaluate Subvisible Particles During Continuous Drug Infusion In a Neonatal Intensive Care Unit
por: Perez, Maxime, et al.
Publicado: (2017)

Evaluation of Strategies for Reducing Vancomycin-Piperacillin/Tazobactam Incompatibility
por: Martin Mena, Anthony, et al.
Publicado: (2023)

Effect of insulin infusion line on glycaemic variability in a perioperative high dependency unit (HDU): a prospective randomised controlled trial
por: Genay, Stéphanie, et al.
Publicado: (2017)

Heparin stability in parenteral nutrition bags prepared in a neonatal ICU
por: Foinard, A, et al.
Publicado: (2014)

Impact of physical incompatibility on drug mass flow rates: example of furosemide-midazolam incompatibility
por: Foinard, Aurélie, et al.
Publicado: (2012)

Effect of multi-lumen perfusion line on catheter-related bacteremia in premature infants: study protocol for a cluster-randomized crossover trial
por: Maiguy-Foinard, Aurélie, et al.
Publicado: (2019)

Association between Urinary Metabolites and the Exposure of Intensive Care Newborns to Plasticizers of Medical Devices Used for Their Care Management
por: Bernard, Lise, et al.
Publicado: (2021)

Influence of a Double-Lumen Extension Tube on Drug Delivery: Examples of Isosorbide Dinitrate and Diazepam
por: Maiguy-Foinard, Aurélie, et al.
Publicado: (2016)

Reply to Otter et al. Comment on “Bernard et al. Association between Urinary Metabolites and the Exposure of Intensive Care Newborns to Plasticizers of Medical Devices Used for Their Care Management. Metabolites 2021, 11, 252”
por: Bernard, Lise, et al.
Publicado: (2021)

Factors Generating Glucose Degradation Products In Sterile Glucose Solutions For Infusion: Statistical Relevance Determination Of Their Impacts
por: Haybrard, J., et al.
Publicado: (2017)

Cefepime extended infusion versus intermittent infusion: Clinical and cost evaluation
por: Khole, Aalok V., et al.
Publicado: (2023)

Does DDI-Predictor Help Pharmacists to Detect Drug-Drug Interactions and Resolve Medication Issues More Effectively?
por: Moreau, Fanny, et al.
Publicado: (2021)

Efficiency of four solutions in removing 23 conventional antineoplastic drugs from contaminated surfaces
por: Simon, Nicolas, et al.
Publicado: (2020)

Cefepime in critically ill patients: continuous infusion versus intermittent regimen
por: Georges, B, et al.
Publicado: (2001)

Cefepime: Cefepime-induced encephalopathy: case report
Publicado: (2022)

A decontamination process adding a tensioactive agent and isopropanol to a closed-system drug transfer device for better control of isolator contamination. A prospective, parallel study
por: Vasseur, Michèle, et al.
Publicado: (2018)

Case Report: Persistent Pulmonary Hypertension of the Newborn and Narrowing of the Ductus Arteriosus After Topical Use of Non-Steroidal Anti-Inflammatory During Pregnancy
por: Le Duc, Kévin, et al.
Publicado: (2021)

Detection of Drug-Related Problems through a Clinical Decision Support System Used by a Clinical Pharmacy Team
por: Robert, Laurine, et al.
Publicado: (2023)

Effectiveness of a Closed-System Transfer Device in Reducing Surface Contamination in a New Antineoplastic Drug-Compounding Unit: A Prospective, Controlled, Parallel Study
por: Simon, Nicolas, et al.
Publicado: (2016)

2687. Extended Infusions of Piperacillin/Tazobactam vs. Cefepime for Empiric Treatment of Neutropenic Fever
por: Norman, Sarah, et al.
Publicado: (2019)

Outcomes of Intravenous Push versus Intermittent Infusion Administration of Cefepime in Critically Ill Patients
por: Smith, Susan E., et al.
Publicado: (2023)

2562. Retrospective Analysis of Cefepime Intravenous Push versus Extended Infusion for the Treatment of Neutropenic Fever
por: Rust, Thomas J, et al.
Publicado: (2023)

Cefepime-induced encephalopathy
por: Kenzaka, Tsuneaki, et al.
Publicado: (2018)

Cefepime-Induced Encephalopathy
por: Keerty, Dinesh, et al.
Publicado: (2021)

Cefepime-Induced Neurotoxicity
por: Saini, Tanjot, et al.
Publicado: (2021)

Cefepime-Induced Delirium
por: Somoza-Cano, Francisco J, et al.
Publicado: (2021)

In Vitro Activity of Two Cefepime-Based Novel Combinations, Cefepime/Taniborbactam and Cefepime/Zidebactam, against Carbapenemase-Expressing Enterobacterales Collected in India
por: Bakthavatchalam, Yamuna Devi, et al.
Publicado: (2023)

In Vitro Activity of Cefepime/AAI101 and Comparators against Cefepime Non-susceptible Enterobacteriaceae
por: Crandon, Jared L., et al.
Publicado: (2015)

Cefepime Therapy for Cefepime-Susceptible Extended-Spectrum β-Lactamase-Producing Enterobacteriaceae Bacteremia
por: Wang, Ruibin, et al.
Publicado: (2016)

1306. Comparison of the Use of Extended and Intermittent Infusion Cefepime and Piperacillin/tazobactam in Non-critically Ill, Obese Patients
por: Marg, Carolyn, et al.
Publicado: (2020)

Cefepime-Resistant Pseudomonas aeruginosa
por: Akhabue, Ehimare, et al.
Publicado: (2011)

Some Pharmacodynamic Aspects of Cefepime
por: Elsayed, Mossad Gamaleddin Ahmed, et al.
Publicado: (2013)

1318. Pharmacokinetics and Safety of Cefepime-Taniborbactam (formerly Cefepime/VNRX-5133) in Subjects with Renal Impairment
por: Geibel, Brooke, et al.
Publicado: (2020)

Influence of borderline cefepime MIC on the outcome of cefepime-susceptible Pseudomonas aeruginosa bacteremia treated with a maximal cefepime dose: a hospital-based retrospective study
por: Su, Ting-Yi, et al.
Publicado: (2017)

Continuous Infusion of High Doses of Cefepime in Intensive Care Unit: Assessment of Steady-State Plasma Level and Incidence on Neurotoxicity
por: Jean-Michel, Vanessa, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_6svhd1okqc28pmojk0oe2vbgkb